![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
8MB |
![[thumbnail of Supplemental Information]](https://mdc-test.eprints-hosting.org/style/images/fileicons/other.png) |
Other (Supplemental Information)
28MB |
| Item Type: | Article |
|---|---|
| Title: | Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signaling |
| Creators Name: | Cheng, J., Li, M., Motta, E., Barci, D., Song, W., Zhou, D., Li, G., Zhu, S., Yang, A., Vaillant, B.D., Imhof, A., Forné, I., Spiegl-Kreinecker, S., Zhang, N., Katayama, H., Bhat, K.P.L., Flüh, C., Kälin, R.E. and Glass, R. |
| Abstract: | The DNA damage response (DDR) and the blood-tumor barrier (BTB) restrict chemotherapeutic success for primary brain tumors like glioblastomas (GBMs). Coherently, GBMs almost invariably relapse with fatal outcomes. Here, we show that the interaction of GBM and myeloid cells simultaneously induces chemoresistance on the genetic and vascular levels by activating GP130 receptor signaling, which can be addressed therapeutically. We provide data from transcriptomic and immunohistochemical screens with human brain material and pharmacological experiments with a humanized organotypic GBM model, proteomics, transcriptomics, and cell-based assays and report that nanomolar concentrations of the signaling peptide humanin promote temozolomide (TMZ) resistance through DDR activation. GBM mouse models recapitulating intratumoral humanin release show accelerated BTB formation. GP130 blockade attenuates both DDR activity and BTB formation, resulting in improved preclinical chemotherapeutic efficacy. Altogether, we describe an overarching mechanism for TMZ resistance and outline a translatable strategy with predictive markers to improve chemotherapy for GBMs. |
| Keywords: | Glioblastoma, Temozolomide, Chemotherapy, Blood-Tumor Barrier, DNA Damage Response, DDR, Humanin, IL6ST, GP130, Tumor-Associated Myeloid Cells, TAM, Animals, Mice |
| Source: | Cell Reports Medicine |
| ISSN: | 2666-3791 |
| Publisher: | Elsevier / Cell Press |
| Volume: | 5 |
| Number: | 8 |
| Page Range: | 101658 |
| Number of Pages: | 1 |
| Date: | 20 August 2024 |
| Official Publication: | https://doi.org/10.1016/j.xcrm.2024.101658 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
